CURE Pharmaceutical Completes $20 Million Acquisition of Sera Labs, a Leading Health, Wellness and Beauty Brand Marketing and Multi-Channel Distribution Platform Company

BusinessWire• September 24, 2020 – Acquisition to Support Cash Flow Positive Goal in ~18 Months – CURE Pharmaceutical Holdings (OTC: CURR) today announced its definitive agreement to acquire Sera Labs, Inc. The closing is anticipated to occur in early October. As previously announced, the transaction consists of an up-front payment of $20 million, of which…